Henry Schein, Inc.

HSIC Healthcare Medical Distribution

Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024.

Revenue
+3.95%
EPS
+34.8%
Free cash flow
−7.09%
Total debt
+15.6%

Quarter to September 2026, against a year earlier

85.40 2.84 −3.22%
Market cap
$9.4B
P/E
22.8×
Fwd P/E
21.3×
Dividend yield
—
F-score
5/9
Altman Z
2.66
Beneish M
−2.51
Dividend safety
69/100

Henry Schein, Inc. (HSIC) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
10-Q Sep 26, 2026 P1I2: no comparison — the Item was not found
P2I1A: no comparison — the Item was not found
8-K Nov 3, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 6, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
8-K Sep 21, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
10-Q Jun 27, 2026 P1I2: no comparison — the Item was not found
P2I1A: no comparison — the Item was not found
8-K Aug 4, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 27, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 21, 2026 5.07 Submission of matters to a vote of security holders; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Mar 28, 2026
8-K May 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 27, 2025 1: 390 added · 317 removed · 375 modified
1A: 243 added · 158 removed · 251 modified
7: 267 added · 494 removed · 191 modified
8-K Feb 24, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 9, 2026 5.02 Departure or appointment of directors or officers; 5.03 Amendments to the articles or bylaws; change in fiscal year; 9.01 Financial statements and exhibits
8-K Dec 23, 2025 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K Dec 19, 2025 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Dec 7, 2025 1.01 Entry into a material definitive agreement
10-Q Sep 27, 2025
8-K Nov 4, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 5, 2025 5.02 Departure or appointment of directors or officers
10-Q Jun 28, 2025
8-K Aug 5, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 29, 2025
8-K May 5, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 28, 2024
8-K Feb 25, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 29, 2025 1.01 Entry into a material definitive agreement; 2.02 Results of operations and financial condition; 3.02 Unregistered sales of equity securities; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Sep 28, 2024
8-K Nov 5, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 29, 2024
8-K Aug 6, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 7, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 27, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Nov 13, 2023 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.